Table 2 Comparison between lost to follow-up and others and between sarcopenic and non-sarcopenic patients at 6-month follow-up
|  | Lost to follow-up at 6 months | Total (N = 83) | p-value | |
|---|---|---|---|---|
No (N = 68) | Yes (N = 15) | |||
Age at enrolment, Mean (SD) | 72.0 (7.0) | 75.1 (6.0) | 72.5 (6.9) | 0.0879 |
GAP stage* | Â | Â | Â | 0.1206 |
 1 | 21 (30.88%) | 2 (13.33%) | 23 (27.71%) |  |
 2 | 36 (52.94%) | 8 (53.33%) | 44 (53, 01%) |  |
 3 | 11 (16.18%) | 4 (26.67%) | 15 (18, 07%) |  |
FVC%*, Mean (SD) | 86.8 (21.9) | 80.5 (18.1) | 85.7 (21.3) | 0.4447 |
DLCO%, Mean (SD) | 53.5 (18.4) | 57.5 (20.1) | 54.2 (18.6) | 0.3818 |
IPAQ*, Mean MET (SD) | 2.2330 (3.1908) | 1.3804 (2.4177) | 2.0771 (3.0685) | 0.0788 |
|  | Sarcopenia at 6-month follow-up | Total (N = 51) | p-value | |
|---|---|---|---|---|
No (N = 40) | Yes (N = 11) | |||
Age at enrolment, Mean (SD) | 69.5 (7.2) | 77.0 (5.6) | 71.1 (7.5) | 0.0021 |
Pneumological visit at 6-month follow-up | Â | Â | Â | Â |
GAP stage | Â | Â | Â | 0.8476 |
 1 | 16 (40.00%) | 3 (27.27%) | 19 (37.25%) |  |
 2 | 14 (35.00%) | 5 (45.45%) | 19 (37.25%) |  |
 3 | 5 (12.50%) | 2 (18.18%) | 7 (13.73%) |  |
 Missing | 5 (12.50%) | 1 (9.09%) | 6 (11.76%) |  |
FVC%°, Mean (SD) | 90.9 (27.0) | 88.2 (15.0) | 90.3 (24.6) | 1 |
DLCO%**, Mean (SD) | 52.6 (17.1) | 45.4 (15.5) | 51.0 (16.9) | 0.2866 |
IPAQ°°, Mean MET (SD) | 2.449.2 (3.4330) | 299.1 (248.5) | 2.0424 (3.1989) | 0.0079 |